Myte Robin, Gylling Björn, Schneede Jörn, Ueland Per Magne, Häggström Jenny, Hultdin Johan, Hallmans Göran, Johansson Ingegerd, Palmqvist Richard, Van Guelpen Bethany
From the aDepartment of Radiation Sciences, Oncology, bDepartment of Medical Biosciences, Pathology, cDepartment of Clinical Pharmacology, Pharmacology and Clinical Neurosciences, Umeå University, Umeå, Sweden; dDepartment of Clinical Science, University of Bergen and Laboratory of Clinical Biochemistry, Haukeland University Hospital, Bergen, Norway; eDepartment of Statistics, Umeå School of Business and Economics, fDepartment of Medical Biosciences, Clinical Chemistry, gDepartment of Biobank Research, Public Health and Clinical Medicine, and hDepartment of Odontology, Cariology, Umeå University, Umeå, Sweden.
Epidemiology. 2016 Nov;27(6):787-96. doi: 10.1097/EDE.0000000000000529.
Despite extensive study, the role of folate in colorectal cancer remains unclear. Research has therefore begun to address the role of other elements of the folate-methionine metabolic cycles. This study investigated factors other than folate involved in one-carbon metabolism, i.e., choline, betaine, dimethylglycine, sarcosine, and methionine and relevant polymorphisms, in relation to the risk of colorectal cancer in a population with low intakes and circulating levels of folate.
This was a prospective case-control study of 613 case subjects and 1,190 matched control subjects nested within the population-based Northern Sweden Health and Disease Study. We estimated odds ratios (OR) by conditional logistic regression, and marginal risk differences with weighted maximum likelihood estimation using incidence data from the study cohort.
Higher plasma concentrations of methionine and betaine were associated with modest colorectal cancer risk reductions (OR [95% confidence interval {CI}] for highest versus lowest tertile: 0.76 [0.57, 0.99] and 0.72 [0.55, 0.94], respectively). Estimated marginal risk differences corresponded to approximately 200 fewer colorectal cancer cases per 100,000 individuals on average. We observed no clear associations between choline, dimethylglycine, or sarcosine and colorectal cancer risk. The inverse association of methionine was modified by plasma folate concentrations (OR [95% CI] for highest/lowest versus lowest/lowest tertile of plasma methionine/folate concentrations 0.39 [0.24, 0.64], Pinteraction = 0.06).
In this population-based, nested case-control study with a long follow-up time from baseline to diagnosis (median: 8.2 years), higher plasma concentrations of methionine and betaine were associated with lower colorectal cancer risk.See Video Abstract at http://links.lww.com/EDE/B83.
尽管进行了广泛研究,但叶酸在结直肠癌中的作用仍不明确。因此,研究已开始关注叶酸-蛋氨酸代谢循环中其他元素的作用。本研究调查了在叶酸摄入量和循环水平较低的人群中,除叶酸外参与一碳代谢的其他因素,即胆碱、甜菜碱、二甲基甘氨酸、肌氨酸、蛋氨酸及相关多态性与结直肠癌风险的关系。
这是一项前瞻性病例对照研究,纳入了基于人群的瑞典北部健康与疾病研究中的613例病例和1190例匹配对照。我们通过条件逻辑回归估计比值比(OR),并使用研究队列的发病数据通过加权最大似然估计法估计边际风险差异。
较高的血浆蛋氨酸和甜菜碱浓度与结直肠癌风险适度降低相关(最高三分位数与最低三分位数相比的OR[95%置信区间{CI}]分别为0.76[0.57,0.99]和0.72[0.55,0.94])。估计的边际风险差异相当于每10万人中平均结直肠癌病例减少约200例。我们未观察到胆碱二甲基甘氨酸或肌氨酸与结直肠癌风险之间存在明确关联。蛋氨酸的负相关关系受血浆叶酸浓度影响(血浆蛋氨酸/叶酸浓度最高/最低三分位数与最低/最低三分位数相比的OR[95%CI]为0.39[0.24,0.64],交互作用P=0.06)。
在这项从基线到诊断有较长随访时间(中位数:8.2年)的基于人群的巢式病例对照研究中,较高的血浆蛋氨酸和甜菜碱浓度与较低的结直肠癌风险相关。见视频摘要:http://links.lww.com/EDE/B83 。